METASTATIC BILIARY TRACT CARCINOMA
Clinical trials for METASTATIC BILIARY TRACT CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC BILIARY TRACT CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC BILIARY TRACT CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer clock: does morning or afternoon treatment work better?
Disease control Not yet recruitingThis study is testing whether the time of day a standard immunotherapy treatment is given affects how well it works for people with advanced solid tumors. Researchers want to see if a patient's internal body clock influences the treatment's effectiveness. About 160 participants w…
Matched conditions: METASTATIC BILIARY TRACT CARCINOMA
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New hope for Tough-to-Treat bile duct cancer: experimental drug added to standard therapy
Disease control Not yet recruitingThis early-stage trial is testing whether adding an experimental drug called emavusertib to standard chemotherapy and immunotherapy helps people with advanced bile duct cancer. Researchers will first find the safest dose, then see how well the combination works to control cancer …
Matched conditions: METASTATIC BILIARY TRACT CARCINOMA
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC